Table 4. Methodological quality markers in the different articles analysed.
Study/tool | Background | Methods | Sample selection | Research tool | Results | Response rates | Interpretation & discussion | Ethics & disclosure | ||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Justification of research methods | Background literature review | Explicit research questions | Clear study objectives | Description of methods used | Method of administration | Number and types of contact | Sample size calculation | Representativeness | Method of sample calculation | Description of the research tool | Instrument pretesting | Instrument reliability & validity | Results of research presented | Results address objectives | Generalizability | Response rate stated | How response rate was calculated | Discussion of non-response rate bias | Interpret and discuss findings | Conclusion | Recommendations | Limitations | Consent | Sponsorship | Research ethics approval | |
Assessments used operationally by professionals | ||||||||||||||||||||||||||
VERA-2 (study A) | + | + | - | + | + | - | - | - | - | - | + | - | - | + | + | - | - | - | - | + | + | - | + | - | - | - |
VERA-2 (study B) | + | + | + | + | + | - | - | + | - | - | + | - | + | + | + | - | - | - | - | + | + | + | + | - | - | - |
ERG 22+ | + | + | + | + | + | + | - | - | - | - | + | - | - | + | + | - | - | - | - | + | + | - | + | + | - | - |
ERS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
IVPG (study A) | + | + | - | + | + | - | - | - | - | - | + | - | - | + | + | - | - | - | - | + | + | - | - | - | - | - |
IVPG (study B) | + | + | - | + | + | + | - | + | + | - | + | - | + | + | + | - | - | - | - | + | + | + | + | - | + | - |
Tools developed as research measures | ||||||||||||||||||||||||||
1992-RWA | + | + | - | - | + | - | - | + | + | - | + | - | + | + | + | - | - | - | - | + | - | - | - | - | - | - |
RF-R | + | + | - | - | + | + | + | + | - | - | + | + | + | + | + | + | - | - | - | + | - | - | - | - | - | - |
PHS | + | + | + | + | + | - | - | + | + | - | + | - | - | + | + | - | + | - | - | + | + | - | - | - | - | - |
MMPI-2 | + | + | + | + | + | - | - | + | + | - | + | - | - | + | + | - | + | - | - | + | + | - | - | - | - | - |
RWA-R | + | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | - | - | - | + | + | - | - | + | - | - |
ITFS | + | + | - | + | + | + | + | + | + | - | + | + | + | + | + | - | + | - | + | + | - | - | - | - | - | - |
ARIS | + | + | + | + | + | + | - | + | + | + | + | + | + | + | + | + | + | - | - | + | + | - | - | - | - | - |
NBMASA | + | + | + | + | + | + | + | + | + | + | + | - | + | + | + | - | + | - | - | + | - | - | - | + | + | + |
MEMS | + | + | + | + | + | + | - | + | + | + | + | - | + | + | + | - | - | - | - | + | - | - | - | - | - | - |
MDFI | + | + | + | + | + | + | + | + | - | + | + | - | + | + | + | + | - | - | - | + | - | - | + | + | - | - |
RF-I | + | + | - | + | + | + | + | + | + | - | + | - | + | + | + | - | - | - | - | + | - | - | - | + | - | - |
SyfoR | + | + | + | + | + | + | + | + | + | + | + | - | + | + | + | + | - | - | - | + | - | + | - | + | - | + |
IFS | + | + | + | + | + | - | - | + | + | + | + | - | + | + | + | - | - | - | - | + | + | - | - | - | - | - |
SSS (studies A-B) | + | + | + | + | + | + | + | + | + | - | + | + | + | + | + | + | + | + | - | + | + | + | + | + | - | - |
ARIS-S | + | + | + | + | + | - | - | + | + | + | + | + | + | + | + | - | - | - | - | + | - | - | - | - | - | - |
Schbley (2003) | + | + | + | + | + | + | + | + | + | - | + | - | + | + | + | - | + | - | - | + | + | + | + | - | + | - |
TCS | + | + | - | + | + | + | - | + | + | - | + | - | + | + | + | - | + | - | - | + | - | + | + | - | - | - |
TRAP-18 | + | + | + | + | + | + | - | - | - | - | + | + | + | + | + | + | - | - | - | + | + | + | + | - | - | - |
+, characteristic present in study;
- characteristic not present in study.